Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections - Concepedia

Concepedia

Publication | Open Access

Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections

DOI Full Paper Access

11

Citations

19

References

2023

Year

Jinyoung Yang, Gunho Won, Jin Yang Baek, Young Ho Lee

Frontiers in Immunology

Abstract

Tixagevimab/cilgavimab provided a comparable neutralizing activity against the BA.5 with a healthy adult population who were vaccinated with a 3<sup>rd</sup> shot and experienced BA.1/BA.2 BI.

References

	Year	Citations

Page 1